drugset / Trial / NCT02494778
A Study Evaluating if Pridopidine is Safe, Efficacious, and Tolerable in Patients With Huntington's Disease
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to collect and assess long term data on the safety, tolerability, and efficacy of pridopidine in patients with Huntington's disease (HD).
Timeline
- Start
- 2015-09-24
- Primary completion
- 2018-01-12
- Completion
- 2018-01-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pridopidine | Small molecule | 45 mg | Oral |